Natera shares tumble after short-seller alleges deceptive billing practices — and possibly insurance fraud

Hindenburg Research — the short-seller firm that writes exposé reports every so often, as in the case of Sorrento Therapeutics in 2020 — went after genetics testing and DNA screening company Natera in its newest report. And the results are far from flattering.